Loading...
Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X
Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...
Saved in:
| Published in: | Iran J Pharm Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Shaheed Beheshti University of Medical Sciences
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5149044/ https://ncbi.nlm.nih.gov/pubmed/27980592 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|